Heterotopic ossification following hip arthroplasty: A comparative radiographic study about its development with the use of three different kinds of implants by Biz, Carlo et al.
Original Citation:
Heterotopic ossification following hip arthroplasty: A comparative radiographic study about its
development with the use of three different kinds of implants
BioMed Central Ltd.
Publisher:
Published version:
DOI:
Terms of use:
Open Access
(Article begins on next page)
This article is made available under terms and conditions applicable to Open Access Guidelines, as described at
http://www.unipd.it/download/file/fid/55401 (Italian only)
Availability:
This version is available at: 11577/3201333 since: 2016-10-20T18:45:59Z
10.1186/s13018-015-0317-2
Università degli Studi di Padova
Padua Research Archive - Institutional Repository
RESEARCH ARTICLE Open Access
Heterotopic ossification following hip
arthroplasty: a comparative radiographic
study about its development with the use
of three different kinds of implants
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Abstract
Background: Our purpose was to record the incidence of heterotopic ossification (HO) following hip replacement
by different variables to identify patient groups that are likely to develop HO in the absence of a prophylactic
protocol.
Methods: Radiographically, we studied 651 patients having undergone hip joint replacement, evaluating three kinds of
implants: ceramic-ceramic-coupled total hip replacement (THR), TriboFit® with polycarbonate urethane-ceramic coupling
and endoprosthesis. Each patient was analysed for HO development by age, gender, diagnosis, presence of previous
ossifications, surgical approach and kind of implant. Within the population that developed HO, data were assessed for
correlation with severity of ossification graded according to Brooker classification.
Results: The overall incidence of HOs was 59.91 %. The factors increasing their incidence in the univariate analysis were
as follows: lower age of the patients with HO (mean 77.6 years, p = 0.0018) than those subjects who did not develop HO
(mean 80.2 years); male gender (64.4 %, p = 0.1011); diagnosis of coxarthrosis (72.7 %, p = 0.0001) compared to femur
neck fracture (55.9 %, p = 0.0001); presence of previous HO (76.2 %, p = 0.0260); lateral approach (65.5 %) as opposed to
anterior-lateral approach (55.6 %, p = 0.0163); and ceramic-ceramic THR (68.1 %) and TriboFit® (67.0 %) compared to
endoprosthesis (51.3 %, p = 0.0001).
During multivariate analysis, the presence of HO after previous hip surgery (p = 0.0324) and the kind of implant
(p = 0.0004) showed to be independent risk factors for the development of HO. Analysing the population that
developed HO, we found that the severity of ossification by Brooker classification was influenced by gender
(p = 0.0478) and kind of implant (p = 0.0093).
Conclusions: In agreement with the literature, our radiographic study confirms the following risk factors of HO
development in absence of any prophylactic treatment: male gender, diagnosis of coxarthrosis compared to femur
neck fracture, previous HO, surgical approach and kind of implant. In particular, Hardinge-Bauer and Watson-Jones
surgical approaches, characterized by a wide exposure of the coxofemoral joint, and ceramic-ceramic THR and TriboFit®
implants significantly increase the development of HO.
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Background
Heterotopic ossification (HO) is the presence of the lamel-
lar bone within soft tissues where the bone physiologically
does not exist. One of the most common forms of HO is
that which intervenes in periarticular soft tissue after hip
replacement, with a mean incidence of 53 % reported in
the literature [1]. Multiple studies have been performed to
date, but aetiopathogenesis of HO is still uncertain. Sev-
eral authors [2–11] have confirmed some risk factors
including male gender, presence of prior HO, previous hip
surgery and lateral and anterolateral hip approaches. Some
pathologies have been associated with a higher rate of
HO, such as ankylosing spondylitis, hypertrophic osteo-
arthritis, diffuse idiopathic skeletal hyperostosis, Paget
disease, Parkinson’s disease and rheumatoid arthritis.
The incidence of HO in hip surgery can be vastly differ-
ent in different ethnic groups. Some studies [2–4, 12]
reported a higher incidence of HO in African-American
patients following acetabular fracture surgery and in
Japanese population because of spastic limb, traumatic
brain injuries, spinal cord lesions, nerve injuries and
neurological disorders, when compared with Europeans.
The most widely used classification system for HO fol-
lowing hip arthroplasty was developed by Brooker et al.
[13] in 1973. Effective measures (NSAIDs, radiation
therapy and selective inhibitors of COX2) to prevent
HO after prosthetic hip surgery are well documented
[14–20]. However, there is no universal agreement as to
which therapeutic protocol is the best.
The aim of this radiographic and retrospective study,
performed on a wide cross-section of patients having
undergone hip replacement, was to record the incidence
of HO by the following variables: three different kinds of
implants, surgical approach, pre-existing HO, age, sex
and diagnosis of diseased hip, as well as identify patient
groups that are likely to develop HO in the absence of a
prophylactic protocol.
Materials and methods
Collection and statistical analysis of data were performed at
our Orthopaedic and Traumatology Clinic during a period
of 24 months, from September 2012 to August 2014, by an
external and independent investigator (PD) not involved in
the patients’ treatment. Information matter of the research
was learnt consulting retrospective case histories, surgical
procedures and radiographic reports from the computer-
ized archives of our hospital. Radiographic data of HO were
obtained reading the radiographic computerized images
taken in the preoperative, postoperative and follow-up pe-
riods, available in the computer system of our institute. We
used a diagnostic LCD CORONIS 3MP display (produced
by Barco, Rome, Italy) as a viewing monitor to determine
the presence and extent of HO.
To classify HOs, we used Brooker classification that
identifies four grades of HO based on an anteroposterior
radiograph of the pelvis:
 Grade 1: the presence of isolated bone fragments of
any size within periarticular soft tissue
 Grade 2: the presence of bone spurs from the pelvis
or femur with at least 1 cm between opposing bone
surfaces
 Grade 3: the presence of bone spurs reducing space
between opposing bone surfaces to less than 1 cm
 Grade 4: ossification with apparent ankylosis of the
hip
In this study, we examined data from a total of 823
patients who underwent, from 2006 to 2013, a surgical
hip replacement in our Orthopaedic Clinic with one of
the following kinds of implant: ceramic-ceramic total hip
replacement (THR), the TriboFit® system with polycar-
bonate urethane-ceramic coupling and endoprosthesis.
All subjects participating in this study received a thor-
ough explanation of this study and gave their oral and
written informed consent to publish the data. The study
was performed in accordance with the ethical standards
of the 1964 Declaration of Helsinki as revised in 2000.
Patients were included in the study on the basis of the
presence in our computerized database of a minimum
follow-up control at 6 months from the surgical interven-
tion (mean follow-up time 32.66 ± 13.17 months; range 6–
72 months). This period was considered the sufficient
minimum to observe the development of HO after hip
surgery. With this premise, data from a total of 651
patients were analysed. None of the patients studied was
treated with prophylactic drugs against formation of peri-
articular HO or other preventive therapies.
The following information was obtained for each
patient from our database:
 Preoperative: age, sex, diagnosis of diseased hip,
pre-existing HO of the hip following prior surgery,
previous hip surgery on the same side
 Operative: surgical approach to the hip, kind of
implant
 Postoperative: presence or absence of periarticular
HO in the surgical hip classified according to
Brooker system as mild (grade 1), moderate (grade
2), severe (grade 3) and very severe (grade 4)
The collected data were statistically assessed for correl-
ation with the development of HO, independently from
their grade, using the chi-square test of independence with
a p value <0.05 as significance level. Then, factors found
to significantly increase development of ectopic bone were
compared individually using multivariate analysis (logistic
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regression) to rule out interdependence. Further, a pos-
sible relationship with statistical significance was analysed
between each singular risk factor and the presence of HO
considering its grade according to Brooker classification.
Storage and statistical analysis of data were performed
using SAS 9.2 (SAS Institute Inc., Cary, NC, USA) for
Windows.
Results
The analysed cohort consisted of 440 women (67.59 %)
and 211 men (32.41 %) with a mean patient age of
78.7 years (range 19–98 years) at the time of surgery.
Diagnosis of diseased hip included traumatic femoral
neck fracture in 517 patients (79.42 %), coxarthrosis in
99 patients (15.21 %) and other diagnoses in 35 patients
(5.37 %). The latter included 11 femoral head necrosis, 1
hip instability, 2 painful THRs, 6 hip surgical revisions for
prosthesis mobilization, 3 surgeries after spacer position-
ing, 2 pathological fractures, 1 revision for intolerance to
metal, 1 hip dysplasia, 2 acetabular fractures, 1 posttrau-
matic stiffness of the hip, 1 pseudoarthrosis after femoral
neck surgery with percutaneous screws, 1 hip arthritis, 2
previous femoral neck surgeries with percutaneous screws
and 1 pertrochanteric fracture with severe coxarthrosis
Fig. 1 Distribution of the diagnoses of a diseased hip. a Main diagnoses. b Diagnoses included under “others”
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(Fig. 1). Forty-two patients (6.45 %) had already developed
HO after previous surgery of the ipsilateral and/or contra-
lateral hip. With regard to the population which under-
went ceramic-ceramic THR, 20 (8.73 %) patients had
already undergone a previous surgical intervention of the
ipsilateral coxofemoral joint. All operations were carried
out adopting one of the following two surgical approaches
to the hip:
1. Transgluteal approach (Hardinge-Bauer) in 223
(34.25 %) patients
2. Anterolateral approach (Watson-Jones) in 401
(61.60 %) patients
For 27 (4.15 %) subjects included in the study, there
were no data available in our archives concerning the
surgical approach to the hip.
Patients underwent hip surgery with three kinds of
implants:
1. Ceramic-ceramic THR: 229 (35.18 %) patients
2. TriboFit® system with polycarbonate urethane-
ceramic coupling: 112 (17.20 %) patients
3. Endoprosthesis: 310 (47.62 %) patients
Periarticular HO formed in 59.9 % (390/651) of the pa-
tients (Fig. 2). Among these, 135 (34.6 %) had mild HO
(grade 1, Brooker classification); 107 (27.4 %) had moderate
HO (grade 2, Brooker classification); 120 (30.8 %) had se-
vere HO (grade 3, Brooker classification); and 28 (7.2 %)
showed very severe HO (grade 4, Brooker classification).
The pictures taken at the operating table show grade 4
HOs that developed in a patient of our cohort who was
moved to the emergency room because of her critical con-
dition after the operation (Fig. 3).
Preoperative and operative independent variables were
considered for those patients who developed periarticular
HO after surgery as shown in Table 1. The mean patient
age at the time of the surgery among those who showed
HO formation was 77.6 years, compared to the mean age
of 80.2 years among those who did not develop HO.
Among male patients, 136 subjects formed HO, whereas
among female they were 254. Periarticular ossification was
found in 289 subjects with preoperative diagnosis of
femoral neck fracture; 72 subjects with diagnosis of coxar-
throsis and 29 subjects with other diagnoses. Among the
population that had shown HO due to previous hip sur-
gery, 32 patients developed HOs compared to 358 among
those who had previously not had HO. Considering only
the patients for whom ceramic-ceramic THR was used,
HO developed in 15 patients who had undergone previous
ipsilateral hip surgery and in 141 patients who had not.
Among patients for whom the surgical approach by
Hardinge-Bauer was chosen, there were 146 subjects with
HO, and among patients for whom the surgical approach
by Watson-Jones was preferred, HO developed in 223
cases. Radiographic signs of HO were found with the fol-
lowing frequencies for each kind of implant: 156 among
ceramic-ceramic THR, 75 among Prosthesis with TriboFit®
technology, 159 among endoprosthesis.
Fig. 2 Frequencies of HO according to Brooker classification
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Multivariate analysis of those risk factors that
reached statistical significance with the chi-square test
was performed. Age (p = 0.7483), sex (p = 0.3528), diag-
nosis of diseased hip (p = 0.1658) and surgical approach
(p = 0.0577) did not show to increase HO individually.
Statistical significance was reached by the presence of
HO after previous hip surgery (p = 0.0324) and the kind of
implant (p = 0.0004). An OR = 2.322 was estimated for
those patients with previous ossification. Patients who
were treated with TriboFit® technology and ceramic-
ceramic THR showed, respectively, an OR = 1.976 and an
OR= 1.911 (Table 2). Within the population that showed
periarticular HO, each risk factor was assessed for correl-
ation with grading of ossification by Brooker classification.
The frequencies obtained are shown in Table 3.
Discussion
Development of periarticular HO can complicate the
postoperative course of healing in those patients who
undergo hip replacement surgery. Principal signs and
symptoms are local pain and decreased joint mobility,
and later, reduced range of motion and ankylosis of the
coxofemoral joint may occur. Fortunately, 80 % or more
cases of HO run an asymptomatic course. Nevertheless,
most studies [1] agree that the radiographic incidence of
HO is approximately 53 % of patients undergoing hip re-
placement without any prophylactic therapy.
This study reports retrospective data from the radio-
graphic analysis of a cohort of 651 patients who underwent
hip replacement surgery with the aim of evaluating the in-
cidence of HO on the basis of different risk factors in the
absence of prophylaxis. Discussing our results together
with those reported in literature, another purpose is to
suggest possible features that make the patients suitable
for preventive measures against HO following hip replace-
ment surgery. Of examined patients, 59.9 % (390/651) de-
veloped periarticular HO following hip replacement
surgery. This result, apparently negative, does not devi-
ate from the mean value reported in similar studies [1]
where patients did not undergo any prophylaxis.
Instead, an aspect that seems relevant is the high per-
centage of cases that showed severe or very severe ossi-
fication by Brooker classification (38 %), with a variable
incidence reported in the literature [7] between 3 and
55 % (Fig. 4). This result could be justified by the choice
of surgical approaches that could have contributed
negatively. In this study, only two surgical approaches
were examined, anterolateral and lateral, both believed
liable to cause a higher incidence of HO by several
authors [9, 10].
A wide meta-analysis published in the Cochrane Library
[14] has proven a reduction of 54–64 % in HO incidence
with an adequate prophylactic therapy. If applied to this
study, these percentages would decrease our incidence of
HO to about 30 %, and it would be a value comparable
with those reported by authors [14] who adopted a
prophylactic therapy. Thus, our data confirm that the
absence of a perioperative prophylaxis seems to be one of
the principal causes of a high incidence of HO. The differ-
ent risk factors implicated in their development are
discussed below.
Age
The mean age of patients who developed HO was
77.6 years, and it was significantly lower (two-sided
p = 0.0018) when compared to that of patients who did
not develop HO (80.2 years). This result refutes some stud-
ies [21] which consider older age as a risk factor for HO.
Sex
Among males, 64.4 % underwent periarticular soft tissue
HO versus 57.7 % of females. Even if this trend is in
agreement with the literature [1, 5, 22], variance in our
study was not statistically relevant (p = 0.1011).
Fig. 3 Case of severe heterotopic ossifications. HOs developed in a
patient who had been moved to the emergency room after
ceramic-ceramic THR because of her critical condition. The patient
remained motionless for 1 month after hip replacement, and 1 year
later, heterotopic ossifications were removed (a, b)
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Diagnosis of diseased hip
Statistical significance was reached comparing the per-
centage of patients who developed HO on the basis of
the diagnosis of diseased hip (p = 0.0001). Femoral neck
fracture predisposes less than coxarthrosis to the devel-
opment of ectopic bone, probably because operating
time is reduced and so are muscular traumatic damage
and bleeding. However, the role of some inflammatory
pathologies (above all, hypertrophic osteoarthritis) as
predictive factors for HO has been well documented in
the literature [7]. In fact, inflammation, which is greater
in osteoarthritis than in acute events like femoral neck
fracture, could justify the difference in the incidences
that we found.
Previous HO
In agreement with the literature [6], patients who devel-
oped HO after previous hip surgery showed a higher
statistically significant frequency (p = 0.0260) of HO than
patients with a history of hip surgery but no HO. This
aspect can be explained with a subjective predisposition
to develop HO.
Previous surgery of the ipsilateral hip
In contrast to the trend found in the literature [6], among
subjects with ceramic-ceramic THR, a statistically signifi-
cant difference was not detected between patients who
had undergone prior ipsilateral hip surgery and those who
had not (p = 0.4896).
Surgical approach to the hip
The comparison between the two surgical approaches to
the hip showed a statistically significant variance on the
formation of periarticular HO (p = 0.0163). The Hardinge-
Bauer surgical approach is a more predisposing factor for
HO development than the Watson-Jones surgical ap-
proach. However, several studies [9, 10] demonstrate that
both surgical approaches predispose the development of
HO more than a posterior approach. A recent study [23]
found that an anterior minimally invasive approach has
some advantages: lower incidence of muscle damage and
haematoma, shorter operative and exposure time, less
bleeding and immediate rehabilitation. All of these are
preventive factors for HO. In particular, prolonged opera-
tive time has been associated to an increased development
of ectopic bone, such as intraoperative blood loss, even if
the latter has not been confirmed by some authors [6, 24].
A minimally invasive anterior approach, where possible, is
to be preferred as opposed to lateral or anterolateral
approaches, to reduce the formation of HO. The possibil-
ity of early rehabilitation given by a minimally invasive
technique also seems to be useful in preventing HO [25].
Some pictures taken at the operating table are shown as
Table 1 Distribution of development of heterotopic ossifications (HO) among patients by rank
Character Rank Presence of HO (%) Absence of HO (%) p values
Age Mean age = 77.6 years Mean age = 80.2 years 0.0018
Sex Male 64.4 35.6 0.1011
Female 57.7 42.3
Diagnosis of diseased hip Coxarthrosis 72.7 27.3 0.0001
Femoral neck fracture 55.9 44.1
Others 82.9 17.1
Previous HO Presence 76.2 23.8 0.0260
Absence 58.8 41.2
Surgical approach to the hip Watson-Jones 55.6 44.4 0.0163
Hardinge-Bauer 65.5 34.5
Kind of implant Ceramic-ceramic THR 68.1 31.9 0.0001
Partial prosthesis 51.3 48.7
TriboFit® system 67.0 33.0
Previous surgery of the ipsilateral hip
(only among ceramic-ceramic THR)
Presence 75.0 25.0 0.4896
Absence 67.5 32.5
Table 2 Odds ratio estimates for those variables that showed to
increase the development of periarticular HO individually during
multivariate analysis
Effect Point estimate 95 % Wald
confidence limits
TriboFit® vs endoprosthesis 1.976 1.251–3.121
Ceramic-ceramic-coupled
THR vs endoprosthesis
1.911 1.326–2.752
Presence of previous HO
vs absence of previous HO
2.322 1.073–5.025
HO heterotopic ossification
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an example of how important early rehabilitation is (Fig. 3).
This patient of our cohort was moved to the emergency
room because of her critical condition before (ASA 3) and
after the operation and remained motionless for about
1 month in the resuscitation unit. The grade 4 HOs that
developed were surgically removed after 1 year.
Kind of implant
The three different kinds of implants that were objects of
study also seemed to have a statistically significant differ-
ence in developing ectopic periarticular bone (p = 0.0001).
While operations carried out with TriboFit® and ceramic-
ceramic-coupled THR were complicated by HO in 67 and
68.1 % of cases, respectively, endoprosthesis showed a
lower incidence (51.3 %). We did not find comparable data
in the literature. Probably, some reasons for this difference
are the shorter operative and exposure time and the lesser
invasivity (most of all, the loss of the acetabular reaming)
that characterizes endoprosthesis when compared to
TriboFit® and ceramic-ceramic-coupled THR. The muscle
damage, which is more probable when arthroprosthesis is
performed, could also play a role in the development of
HO. Thus, hip replacement with endoprosthesis reduces
the incidence of ectopic ossification; this aspect should be
considered when the kind of implant is chosen in border-
line cases.
Multivariate analysis
During the multivariate analysis of those risk factors that
reached statistical significance with the chi-square test,
variables that showed to individually increase HO inci-
dence were the presence of HO after previous hip surgery
(p = 0.0324) and the kind of implant (p = 0.0004). In
particular, an OR = 2.322 was estimated for those patients
with previous ossification in comparison to those patients
who had undergone prior hip surgery without HO.
Patients who were treated with TriboFit® technology
and ceramic-ceramic THR showed, respectively, an
OR = 1.976 and an OR = 1.911 compared to patients
treated with endoprosthesis.
Within the population of subjects that showed peri-
articular HO, each detected variable was assessed for
correlation with the severity of ossification according to
Brooker classification. Factors that did not indicate a
significant influence on grading of ossification were
diagnosis of diseased hip (p = 0.3278), surgical approach
to the hip (p = 0.1738) and HO due to previous hip sur-
gery (p = 0.2830).
Development of HO following Brooker classification
On the other hand, association between the severity of
HO and the following factors turned out to be statisti-
cally significant:
1. Kind of implant (p = 0.0093). In particular, with
patients who underwent ceramic-ceramic-coupled
THR and TriboFit®, respectively, 37.2 and 53.3 % of
cases developed ossification of grades 3 and 4, versus
31.4 % of patients whose implant was an
endoprosthesis.
2. Gender (p = 0.0478). Male patients showed a
percentage of 44.8 % of severe or very severe
ossification, versus 34.2 % of female patients, in
agreement with literature data [1, 5, 22].
Some data presented in this study may encourage im-
provement of the prophylactic drugs against formation
of periarticular HO and early rehabilitation. However,
our study shows some weaknesses, which should be
pointed out. First of all, we did not consider the clinical
Table 3 Distribution of development of heterotopic ossifications (HO) among patients by the grade of HO
Character Rank HO grade by Brooker classification (%) p values
1 2 3 4
Sex Male 26.5 28.7 34.5 10.3 0.0478
Female 39.0 26.8 28.7 5.5
Diagnosis of diseased hip Coxarthrosis 40.3 20.8 29.2 9.7 0.3278
Femoral neck fracture 33.6 28.4 32.1 5.9
Others 31.0 34.5 20.7 13.8
Previous HO Presence 40.6 38.4 15.6 9.4 0.2830
Absence 34.1 26.8 32.1 7.0
Surgical approach to the hip Watson-Jones 38.1 28.7 26.9 6.3 0.1738
Hardinge-Bauer 30.8 24.7 37.0 7.5
Kind of implant Ceramic-ceramic THR 37.2 25.6 26.9 10.3 0.0093
Partial prosthesis 35.2 33.3 27.1 4.4
TriboFit® system 28.0 18.7 46.7 6.6
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counterpart of the HOs found. Usually, radiographic HO
is not related to clinical course and most HOs occur
asymptomatically; they may, however, involve clinical
impairment, such as decreased hip range of motion and
function and pain [26–28]. Hence, we strongly believe
that further research is necessary to establish a relation-
ship between the radiographic grade of HO and its clin-
ical aspect. Another apparent point of weakness is that
we considered the presence in our computerized data-
base of a minimum follow-up control at 6 months from
hip surgery as an inclusion criterion (only nine patients
with a minimum follow-up of 6 months, seven patients
with an 8-month follow-up and six with a 10-month
follow-up). Considering this period reasonable to ob-
serve or predict the development of HO, we could have
slightly underestimated the number of patients which
developed HO and, in particular, the number of severe
and very severe HOs (grades 3 and 4 by Brooker classifi-
cation). However, HO is usually evident from radio-
graphs by 6 weeks after surgery. Hence, the ossification
Fig. 4 Examples of radiographic high-graded heterotopic ossification for each kind of implant within our cohort. a Ceramic-ceramic-coupled total
hip replacement. b TriboFit®. c Endoprosthesis
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matures throughout the first 6 months and then gener-
ally does not develop further thereafter [13, 26, 27].
Finally, the fact that our institute is a trauma clinic could
have introduced some difficulties of interpretation. In par-
ticular, 80 % of the population studied suffered from fem-
oral neck fracture and only 15 % from coxarthrosis. A bias
towards endoprosthesis in fracture and THR in hip
osteoarthrosis is plausible. However, we used logistic re-
gression as our statistical modelling method to control
confounding variables as much as possible. According to
our knowledge, in the literature, there are no comparable
data about the relationship between HO and the kind of
implants considered in this study. This variable was shown
to affect the development of HO in our research, and fur-
ther studies are needed to confirm our results. Moreover,
the presence of a higher incidence of HO in African-
American patients following acetabular fracture surgery
[12] and in the Japanese population because of multiple
injuries, nerve injuries and ossificans diseases [2–4] should
be investigated further. In addition, our data should be
compared with other ethnic groups as our study was con-
ducted only with a cohort of Caucasian subjects.
Conclusions
The development of HO following hip replacement sur-
gery is affected by endogenous and exogenous factors.
Our radiographic study confirms, in agreement with the
literature, some risk factors, such as previous HO of soft
tissue around the hip, kind of implant, surgical ap-
proach to the hip, diagnosis of coxarthrosis versus fem-
oral neck fracture and male gender. On the other hand,
there are factors in contrast with some of the authors’
outcomes, such as older age. In particular, Hardinge-
Bauer and Watson-Jones surgical approaches, charac-
terized by a wide exposure of the coxofemoral joint, and
ceramic-ceramic THR and TriboFit® significantly favour
the formation of HO. Thus, we think that orthopaedic
surgeons should prefer alternative surgical approaches
and minimally invasive implants. Furthermore, our
results and literature data suggest that a prophylactic
treatment could be a choice to drastically decrease the
incidence of HO after hip replacement surgery. We
believe it is necessary to carry out a controlled and
randomized study as a valid aid for the choice of the
most appropriate therapeutic option according to differ-
ent categories of patients.
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